{"alanine aminotransferase increased": 3.57, "amylase increased": 6.61, "anaemia": 2.71, "ascites": 4.65, "aspartate aminotransferase increased": 3.44, "blast crisis in myelogenous leukaemia": 150.5, "blood alkaline phosphatase increased": 2.6, "blood bilirubin increased": 5.8, "blood creatine phosphokinase increased": 2.73, "blood creatinine increased": 2.65, "blood lactate dehydrogenase increased": 7.0, "blood urea increased": 3.43, "c-reactive protein increased": 2.07, "cardiac failure": 3.75, "chronic myeloid leukaemia": 88.31, "cytogenetic analysis abnormal": 162.57, "cytopenia": 5.61, "drug interaction": 4.0, "drug intolerance": 6.51, "drug level increased": 4.15, "drug resistance": 14.76, "dyspnoea exertional": 2.09, "electrocardiogram qt prolonged": 2.11, "eyelid oedema": 5.83, "face oedema": 3.42, "fluid retention": 4.38, "gamma-glutamyltransferase increased": 2.55, "gastrointestinal stromal tumour": 299.03, "generalised oedema": 10.93, "haemoglobin decreased": 3.49, "hepatic cytolysis": 4.03, "interstitial lung disease": 4.16, "leukopenia": 2.37, "liver disorder": 3.68, "maligt neoplasm progression": 12.7, "metastases to liver": 17.71, "metastases to peritoneum": 36.01, "neoplasm progression": 3.79, "neoplasm recurrence": 55.79, "oedema": 8.67, "oedema peripheral": 3.69, "pancytopenia": 7.22, "pericardial effusion": 3.55, "periorbital oedema": 9.05, "platelet count decreased": 4.47, "pleural effusion": 10.58, "renal impairment": 2.03, "second primary maligcy": 23.91, "skin exfoliation": 2.2, "subdural haematoma": 4.99, "therapeutic response decreased": 5.93, "therapy non-responder": 3.08, "thrombocytopenia": 2.3, "transaminases increased": 2.45, "treatment failure": 2.67, "white blood cell count decreased": 3.77, "white blood cell count increased": 7.86}